Dyne Therapeutics, Inc. (DYN) — Net Income
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$446.21M | -40.6% |
| 2024 | -$317.42M | -34.5% |
| 2023 | -$235.94M | -40.4% |
| 2022 | -$168.10M | -12.6% |
| 2021 | -$149.29M | -151.2% |
| 2020 | -$59.44M | -300.0% |
| 2019 | -$14.86M | — |
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$446.21M | -40.6% |
| 2024 | -$317.42M | -34.5% |
| 2023 | -$235.94M | -40.4% |
| 2022 | -$168.10M | -12.6% |
| 2021 | -$149.29M | -151.2% |
| 2020 | -$59.44M | -300.0% |
| 2019 | -$14.86M | — |